# Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats

> **NCT00529490** · PHASE3 · COMPLETED · sponsor: **Innogene Kalbiotech Pte. Ltd** · enrollment: 230 (actual)

## Conditions studied

- Low Cardiac Output

## Interventions

- **DRUG:** Hypertonic lactate
- **DRUG:** Ringer's lactate

## Key facts

- **NCT ID:** NCT00529490
- **Lead sponsor:** Innogene Kalbiotech Pte. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** 2003-06
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2007-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00529490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00529490, "Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00529490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*